STABLE PHARMACEUTICAL FORMULATION

This invention relates to a novel granulate and a novel oral solid dosage formulation, each comprising an active ingredient and one or more carriers prepared by a novel wet granulation method. This method provides that the mixture of active ingredient and carrier be kept below 40° C. during the gran...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GRONLUND, PER, RASMUSSEN, STELLA RUDKJAER
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	GRONLUND, PER RASMUSSEN, STELLA RUDKJAER
description	This invention relates to a novel granulate and a novel oral solid dosage formulation, each comprising an active ingredient and one or more carriers prepared by a novel wet granulation method. This method provides that the mixture of active ingredient and carrier be kept below 40° C. during the granulation process such that a more stable formulation is obtained.
format	Patent
fullrecord	<record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_20020022649</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20020022649</sourcerecordid><originalsourceid>FETCH-uspatents_applications_200200226493</originalsourceid><addsrcrecordid>eNrjZFAMDnF08nFVCPBwDPJ1dHYNDfF0dvRRcPMP8g31cQzx9PfjYWBNS8wpTuWF0twMmm6uIc4euqXFBYklqXklxfGJBQU5mcmJJZn5ecXxRgYGIGRkZmJpTIpaAOpyKVw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE PHARMACEUTICAL FORMULATION</title><source>USPTO Published Applications</source><creator>GRONLUND, PER ; RASMUSSEN, STELLA RUDKJAER</creator><creatorcontrib>GRONLUND, PER ; RASMUSSEN, STELLA RUDKJAER</creatorcontrib><description>This invention relates to a novel granulate and a novel oral solid dosage formulation, each comprising an active ingredient and one or more carriers prepared by a novel wet granulation method. This method provides that the mixture of active ingredient and carrier be kept below 40° C. during the granulation process such that a more stable formulation is obtained.</description><language>eng</language><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20020022649$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,873,885,64059</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/09358024$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GRONLUND, PER</creatorcontrib><creatorcontrib>RASMUSSEN, STELLA RUDKJAER</creatorcontrib><title>STABLE PHARMACEUTICAL FORMULATION</title><description>This invention relates to a novel granulate and a novel oral solid dosage formulation, each comprising an active ingredient and one or more carriers prepared by a novel wet granulation method. This method provides that the mixture of active ingredient and carrier be kept below 40° C. during the granulation process such that a more stable formulation is obtained.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNrjZFAMDnF08nFVCPBwDPJ1dHYNDfF0dvRRcPMP8g31cQzx9PfjYWBNS8wpTuWF0twMmm6uIc4euqXFBYklqXklxfGJBQU5mcmJJZn5ecXxRgYGIGRkZmJpTIpaAOpyKVw</recordid><startdate>20020221</startdate><enddate>20020221</enddate><creator>GRONLUND, PER</creator><creator>RASMUSSEN, STELLA RUDKJAER</creator><scope>EFI</scope></search><sort><creationdate>20020221</creationdate><title>STABLE PHARMACEUTICAL FORMULATION</title><author>GRONLUND, PER ; RASMUSSEN, STELLA RUDKJAER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_200200226493</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2002</creationdate><toplevel>online_resources</toplevel><creatorcontrib>GRONLUND, PER</creatorcontrib><creatorcontrib>RASMUSSEN, STELLA RUDKJAER</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GRONLUND, PER</au><au>RASMUSSEN, STELLA RUDKJAER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE PHARMACEUTICAL FORMULATION</title><date>2002-02-21</date><risdate>2002</risdate><abstract>This invention relates to a novel granulate and a novel oral solid dosage formulation, each comprising an active ingredient and one or more carriers prepared by a novel wet granulation method. This method provides that the mixture of active ingredient and carrier be kept below 40° C. during the granulation process such that a more stable formulation is obtained.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_uspatents_applications_20020022649
source	USPTO Published Applications
title	STABLE PHARMACEUTICAL FORMULATION
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A32%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GRONLUND,%20PER&rft.date=2002-02-21&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20020022649%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true